Kiniksa Pharmaceuticals International Plc (KNSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 22,592 | 59,005 | 44,806 | 26,371 | 8,539 |
| Depreciation Amortization | 468 | 1,554 | 1,087 | 703 | 345 |
| Income taxes - deferred | 4,523 | 13,002 | 9,864 | 5,637 | 2,993 |
| Accounts receivable | -7,630 | 26,130 | -10,018 | 9,814 | 1,659 |
| Accounts payable and accrued liabilities | 22,266 | 142 | 4,264 | 6,992 | 62 |
| Other Working Capital | 10,318 | 24,791 | -1,084 | -67 | 1,599 |
| Other Operating Activity | -2,338 | 13,361 | 35,172 | 964 | 7,127 |
| Operating Cash Flow | $50,199 | $137,985 | $84,091 | $50,414 | $22,324 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -31,755 | -187,425 | -117,244 | -55,160 | -51,442 |
| PPE Investments | -161 | -1,568 | -935 | -264 | -99 |
| Investing Cash Flow | $-31,916 | $-188,993 | $-118,179 | $-55,424 | $-51,541 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,389 | 40,753 | 32,177 | 15,925 | 3,180 |
| Other Financing Activity | -316 | -7,730 | -6,812 | -2,459 | -412 |
| Financing Cash Flow | $6,073 | $33,023 | $25,365 | $13,466 | $2,768 |
| Beginning Cash Position | 165,596 | 183,581 | 183,581 | 183,581 | 183,581 |
| End Cash Position | 189,952 | 165,596 | 174,858 | 192,037 | 157,132 |
| Net Cash Flow | $24,356 | $-17,985 | $-8,723 | $8,456 | $-26,449 |
| Free Cash Flow | |||||
| Operating Cash Flow | 50,199 | 137,985 | 84,091 | 50,414 | 22,324 |
| Capital Expenditure | -161 | -1,568 | -935 | -264 | -99 |
| Free Cash Flow | 50,038 | 136,417 | 83,156 | 50,150 | 22,225 |